• November 1, 2026
  • Last Update November 1, 2026 1:52 pm

durvalumab

  • October 14, 2026

Breakthrough Immunotherapy Offers New Hope in the Fight Against Gastric Cancer in Costa Rica

San José, Costa Rica — A significant advancement in oncology is expanding treatment options for adults diagnosed with operable gastric…
  • July 21, 2026

Costa Rica Approves Groundbreaking AstraZeneca Immunotherapy for Bladder Cancer Patients

San José, Costa Rica — Costa Rica’s medical regulatory landscape has marked a significant milestone with the approval of AstraZeneca’s…